Abstract
With the rapid development of high-throughput genomic technologies and the accumulation of genome-wide datasets for human disease, it has been shown that using only reductionistic principles has been difficult to capture the complex biological networks and design rational medication. However, the emerging paradigm of “network based methodology” proposes to harness the power of networks to uncover relationships between various data types of interest for drug discovery. Recent advances include networks that encompass relationships between drugs, disease-related genes, therapeutic targets and diseases. It is shown how network techniques can help in the investigation of the mechanism of action of existing drugs, new molecules, or to identify novel disease genes and targets. We review how these different types of network analysis approaches facilitate drug discovery and their associated challenges. Some representative examples are reviewed to show that network analysis is a powerful, integrated, computational and experimental approach to improve the drug discovery process.
Keywords: Drug discovery, target identification, network analysis.
Mini-Reviews in Medicinal Chemistry
Title:Network based Approach to Drug Discovery: A Mini Review
Volume: 15 Issue: 8
Author(s): Peng Li, Yingxue Fu and Yonghua Wang
Affiliation:
Keywords: Drug discovery, target identification, network analysis.
Abstract: With the rapid development of high-throughput genomic technologies and the accumulation of genome-wide datasets for human disease, it has been shown that using only reductionistic principles has been difficult to capture the complex biological networks and design rational medication. However, the emerging paradigm of “network based methodology” proposes to harness the power of networks to uncover relationships between various data types of interest for drug discovery. Recent advances include networks that encompass relationships between drugs, disease-related genes, therapeutic targets and diseases. It is shown how network techniques can help in the investigation of the mechanism of action of existing drugs, new molecules, or to identify novel disease genes and targets. We review how these different types of network analysis approaches facilitate drug discovery and their associated challenges. Some representative examples are reviewed to show that network analysis is a powerful, integrated, computational and experimental approach to improve the drug discovery process.
Export Options
About this article
Cite this article as:
Li Peng, Fu Yingxue and Wang Yonghua, Network based Approach to Drug Discovery: A Mini Review, Mini-Reviews in Medicinal Chemistry 2015; 15 (8) . https://dx.doi.org/10.2174/1389557515666150219143933
DOI https://dx.doi.org/10.2174/1389557515666150219143933 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer’s, Parkinson’s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation
Current Medicinal Chemistry Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection
Current Cancer Drug Targets Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry Recent Advances in Pharmacokinetics of Polymeric Excipients Used in Nanosized Anti-Cancer Drugs
Current Drug Metabolism An Overview of Data Mining Algorithms in Drug Induced Toxicity Prediction
Mini-Reviews in Medicinal Chemistry Targeted Therapy for Glioblastoma: Lessons Learned and Future Directions
Current Cancer Therapy Reviews Expanding Opportunities in Treatment of Leukemia by Solid Lipid Nanoparticles
Letters in Drug Design & Discovery Environmental Chemicals and Breast Cancer Risk – A Structural Chemistry Perspective
Current Medicinal Chemistry Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment
Recent Patents on Anti-Cancer Drug Discovery MDM2 Inhibitors for Pancreatic Cancer Therapy
Mini-Reviews in Medicinal Chemistry Chitinases: Biomarkers for Human Diseases
Protein & Peptide Letters Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Current Cancer Drug Targets Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer
Current Signal Transduction Therapy Genes that Modulate the Sensitivity for Anti-Microtubule Drug-Mediated Chemotherapy
Current Cancer Drug Targets From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets Synergy Against Fungal Pathogens: Working Together is Better Than Working Alone
Current Medicinal Chemistry Stent-Based Delivered Anti-Proliferative Drugs in the Prevention of Coronary Stent Restenosis
Current Medicinal Chemistry - Cardiovascular & Hematological Agents A Review on Exploring Better Safety Prospects in Managing Cancer using Liposomal Combinations of Food Bioactive Compounds and Anticancer Drugs: Combisomes
Current Drug Delivery